Enanta Pharmaceuticals | ENTA - Market Capitalization


Enanta Pharmaceuticals reported $264M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Incyte USD 19.39B 2.83B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Novavax USD 1.43B 340M Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025